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Smooth muscle contraction depends on the state of myosin phosphorylation and hence on the balance of 
myosin light chain kinase and phosphatase activity. Effects of okadaic acid isolated from black sponge on 
both enzyme activities and contractility were studied in chemically skinned fibers from guinea pig taenia 
coli. The toxin strongly inhibits myosin phosphatase and enhances tension development. 
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1. INTRODUCTION 
Okadaic acid (OA), a toxin isolated from black 
sponges [l], has marked contractile effects on the 
vascular and intestinal smooth muscles [2] and the 
heart muscle [3]. OA increases the slow inward 
current in the heart muscle [3] whereas it does not 
affect the ATPase activities of the Na+-K+ pump 
and smooth muscle myosin [2]. Recently, it was 
reported that OA enhanced the contraction of 
guinea pig taenia coli fibers skinned with Triton 
X-100 at low levels of Ca2+ [4]. These findings 
strongly indicate that the effect of OA on smooth 
muscle tissue are produced by its direct interaction 
with intracellular regulatory mechanisms that ac- 
tivate contraction via phosphorylation of myosin 
light chains. As the state of phosphorylation 
depends on the balance of activities of calmodulin- 
dependent myosin light chain kinase (MLCK) and 
myosin light chain phosphatase, we have examined 
the effect of OA on these enzymic activities as well 
as on tension development of skinned fibers of 
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guinea pig taenia coli. We report that OA has a 
specific inhibitory action on myosin phosphatase 
thereby abolishing its activity at micromolar con- 
centrations. 
2. MATERIALS AND METHODS 
Guinea pig taenia coli was skinned in a 1% 
Triton X-100 solution and stored in a glycerol solu- 
tion [5]. The skinned fibers were used within five 
days after skinning either for mechanical ex- 
periments or for enzyme assays. 
Both solutions for mechanical experiments and 
the reaction mixture for enzyme analyses contain- 
ed (in mM): imidazole (30), EGTA (4), KH2P04 
(6) and dithioerythritol (DTE; 2); adjusted to pH 
6.7 with KOH. The free Ca2+ concentration was 
varied by changing the ratio of EGTA to Ca- 
EGTA, assuming the apparent dissociation cons- 
tant of 1.6 PM [6]. Except for the measurement of 
protein phosphatase activity, the solution also con- 
tained 0.2pM calmodulin. For mechanical ex- 
periments, 7.5 mM adenosine 5’-triphosphate 
(ATP), 10 mM creatine phosphate and 50 U/ml 
creatine kinase were supplemented. In enzyme 
analyses, 1 mg/ml bovine serum albumin (BSA) 
was added to the reaction mixture, and tempera- 
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ture was maintained at 30°C. The mechanical ex- 
periments were performed at room temperature 
(about 23°C). OA was dissolved in dimethylsulfox- 
ide (DMSO) and added to the solutions. The same 
amount of DMSO (O.l-0.5% vol.) was added to 
the control solutions, too. The mechanical 
response was not altered when ethanol was used in- 
stead of DMSO. The isometric tension was record- 
ed using an AME 801 force transducer (SensoNor, 
Horten, Norway) [7]. 
In the enzyme analyses, the fiber was homoge- 
nized in a solution (5 ml/g) containing (in mM): 
imidazole (30), DTE (2), phenylmethylsulfonyl 
fluoride (PMSF; 0.1) and KC1 (20). The homoge- 
nate was centrifuged for 15 min at 17 500 x g, and 
resulting supernatant was used for the enzyme 
analyses of protein phosphatase and MLCK. 
Bovine aortic myosin phosphatase was extracted 
and purified as described [8]. 
Protein phosphatase activity was measured by a 
modification of the isotope method [9], using 
isolated bovine heart light chains [7] which had 
been 32P-phosphorylated [lo] by chicken gizzard 
MLCK [ 1 l] as substrate. MLCK activity was deter- 
mined by measuring the incorporation of 32P from 
[T-~~P]ATP into the bovine heart light chains [l 11. 
Calcium/calmodulin-dependent phosphodiester- 
ase (PDE) activity was measured by modification 
of the method described for calmodulin measure- 
ment [ 121. Briefly, adenosine 3 ‘,5 ‘-cyclic mono- 
phosphate (CAMP) was degraded to inosine with 
3 mu/ml PDE, 30 U/ml alkaline phosphatase 
(AP) and 4 U/ml adenosine deaminase (ADA) in 
the presence of 0.2 PM calmodulin and various 
concentrations of calcium, and the rate of decrease 
in absorbance was measured at 265 nm. Protein 
was determined by the Lowry method 1131 using 
BSA as the standard. 
Numerical data were presented as means f SE, 
and the difference was evaluated by the Student’s 
t-test. Concentration-response r lations were fitted 
by the Hill function with the least-square method, 
and the difference was examined by a method of 
covariance analysis [14]. In both cases, prob- 
abilities smaller than 0.05 were evaluated as signifi- 
cant. 
OA, isolated from the black sponge Halichon- 
dria okadai, was a generous gift from Dr Y. 
Tsukitani (Fujisawa Pharmaceutical Company, 
Tokyo, Japan). Calmodulin (from porcine brain), 
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PDE (from bovine heart), AP and ADA were ob- 
tained from Boehringer Mannheim, FRG. 
3. RESULTS 
3.1. Mechanical effect 
It was confirmed that OA has a contractile effect 
on the chemically skinned taenia coli fiber (fig. 1). 
The fiber was first immersed in calcium-free solu- 
tion (Ca’+ < 1 nM) and then maximally contracted 
by applying a solution containing 30 FM Ca2+ and 
0.2pM calmodulin. When a steady level was ap- 
proached, Ca2+ concentration was reduced to 
1.5 FM to induce a partial relaxation, and when a 
plateau was reached, 5 PM OA were added. OA 
produced an immediate increase in tension, which 
was completely reversed when OA was washed out. 
No response was observed when OA was applied to 
the fiber relaxed in calcium-free solution (not 
shown). 
Fig.2 shows the dose-response relationship of 
the effect. The response was normalized to the 
maximal contraction produced by 30pM Ca2+ 
(control 0.6 f 0.1 mN (n = 22)). The data are 
presented as percentages of the response with 
10 PM OA which was 80 t- 6% of the control 
(n = 5). From this curve the concentration for 50% 
response (EDTO) of 0.67 PM OA was obtained. 
3.2. Inhibition of protein phosphatase 
As shown in fig.3, OA produced a dose- 
dependent inhibition of the phosphatase activity. 
The measurement was carried out in calcium-free 
5 p’M OA 
1 0 2mN 
Fig. 1. Mechanical effect of okadaic acid (OA) on the 
Triton X-100 skinned fiber. See text for explanation. 
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Fig.2. Dose-response relationship of mechanical 
response. Data were obtained by the same type of ex- 
periments as in fig. 1. Various concentrations of okadaic 
acid (OA) were applied at the constant Ca2+ concentra- 
tion of 1.5 &I. 
solution in order to suppress the MLCK activity 
(see below). The specific activity was 1.42 + 0.07 
nmol P/min per mg protein (n = 6) when measured 
using 4 ,uM 32P-labelled light chains as substrate 
(= 100% activity), and this was almost completely 
inhibited by 5-10 pM OA. The dose response was 
well fitted by the theoretical function with a Hill 
coefficient of 0.88, and from this the concentra- 
tion for 50% inhibition (IDso) of 14 nM was ob- 
tained. The purified aortic phosphatase with a 
specific activity of 1600 nmol P/min per mg pro- 
tein was inhibited by 98 + 2% (n = 6) in the 
presence of 5 PM OA. The Michaelis constant K,,, 
of 0.8 ,uM was obtained for the purified enzyme 
from the dependence of initial velocity on sub- 
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Fig.3. Inhibition of protein phosphatase activity in the 
taenia coli extract by okadaic acid. A dose-inhibition 
relationship. 
strate concentration (0.4-8 ,uM phosphorylated 
light chains). 
3.3. No effect on MLCK and PDE 
OA had no effects on the MLCK activity (fig.4). 
The MLCK activity in the presence of 30 yM Ca2+ 
was 46 + 3 nmol P/min per mg protein (n = 8), 
and all data presented are given as percentages of 
this control activity. In calcium-free solution, the 
MLCK activity was 0.56 + 0.07% of the control 
(n = 16). This small but significant @ < 0.0001) 
residual activity, which was not affected by 5 pM 
OA, has been subtracted from all data. The Ca2+ 
concentration-activity relationship was not altered 
by 5 PM OA. In order to minimize the interference 
by protein phosphatase activity, which was 
32-times lower than that of MLCK (see above), the 
concentration of phosphorylated light chain was 
not allowed to exceed 0.1 PM even at the end of the 
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Fig.4. Ca2+ concentration-activity relationship of 
myosin light chain kinase (MLCK; upper panel, n = 8) 
and phosphodiesterase (PDE; lower panel, n = 3) in the 
absence (0) and in the presence (A) of 5 PM okadaic 
acid. Vertical bars indicating SE are omitted when they 
are within the symbols. 
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reaction time of 5 min by diluting the extract 300 
times (at the final mixture). 
5 PM OA had no effect on the calcium/cal- 
modulin-dependent activity of PDE over the range 
of Ca2+ concentrations examined, indicating that 
OA does not affect calmodulin (fig.4). The activity 
is presented as a percentage of the activity in the 
presence of 30 PM Ca’+. In calcium-free solution, 
the activity was undetectably low. 
4. DISCUSSION 
According to the phosphorylation theory of 
smooth muscle activation, contractile force 
depends on the state of myosin light chain phos- 
phorylation which is dependent on the balance of 
myosin phosphatase and calcium/calmodulin- 
dependent myosin light chain kinase. Myosin 
phosphatase inhibitors against endogenous myosin 
light chain phosphatases of high molecular masses 
have not been described so far [ 151. The present ex- 
periments how that OA has a powerful inhibitory 
effect on myosin phosphatase but no effect on 
myosin light chain kinase and calmodulin. Fur- 
thermore, the effect is not limited to the protein 
phosphatase(s) of the taenia extract because the 
purified aortic phosphatase was similarly in- 
hibited. The results also confirm an earlier study 
[5] showing that OA increases force development 
of submaximally activated chemically skinned 
taenia coli fibers. Maximal mechanical response 
and a nearly complete inhibition of myosin phos- 
phatase are both observed with 5 yM OA sug- 
gesting that these two phenomena are causally 
related. Indeed, the contractile response of the 
skinned taenia coli fibers to OA was accompanied 
by an increase in light chain phosphorylation 
(from 29 f 3% to 53 f 2% with 5 PM OA in the 
presence of 1 PM Ca’+; n = 4), and relaxation by 
calcium removal was strikingly slowed in the 
presence of OA (unpublished observations). 
To our knowledge, OA is the first potent and 
reversible myosin phosphatase inhibitor, and it 
may, in the future, serve as a unique tool for 
analyzing phosphorylation-dependent activation 
or inhibition mechanisms in muscle contraction 
and cell motility. 
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